Grup de recerca translacional vascular i renal
Responsable de grup
Publicacions (443)
Fernández, LM; Sánchez-Alvarez, JE; de la Tassa, CM; Fernández, JJB; María, V; Fernández, E; Valdivielso, JM; Betriu, A
Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA study
NEFROLOGIA 41 337-346. .
Kosanovic M; Llorente A; Glamoclija S; Valdivielso JM; Bozic M
Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
Del Vecchio, L; Ekart, R; Ferro, CJ; Malyszko, J; Mark, PB; Ortiz, A; Sarafidis, P; Valdivielso, JM; Mallamaci, F; ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group
Intravenous iron therapy and the cardiovascular system: risks and benefits.
Clinical Kidney Journal 14 1067-1076. .
Roca N; Martinez C; Jatem E; Madrid A; Lopez M; Segarra A
Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.
Clinical Kidney Journal 14 1207-1215. .
Dòria M; Betriu À; Belart M; Rosado V; Hernández M; Sarro F; real j; Castelblanco E; Pacheco LR; Fernández E; Franch-Nadal J; Gratacòs M; Mauricio D
High Incidence of Adverse Outcomes in Haemodialysis Patients with Diabetes with or without Diabetic Foot Syndrome: A 5-Year Observational Study in Lleida, Spain.
Journal of Clinical Medicine 10 -. .
Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
BMC Nephrology 22 110-110. .
Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A
Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.
Nutrients 13 1-15. .
Sapiña-Beltrán E; Gracia-Lavedan E; Torres G; Gaeta AM; Paredes J; Mayoral A; Fernández E; Bermúdez-López M; Valdivielso JM; Farràs-Salles C; Pamplona R; Lecube A; de Batlle J; Barbé F; Dalmases M
Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild-Moderate Cardiovascular Risk.
ARCHIVOS DE BRONCONEUMOLOGIA 58 490-497. .
Acha, P; Hoyos, M; Pratcorona, M; Fuster-Tormo, F; Palomo, L; Ortega, E; Zamora, L; Vives, S; Granada, I; Montoro, J; Garcia, A; Arnan, M; Cervera, M; Canet, M; Gallardo, D; Arenillas, L; Esteve, J; Baragay, J; Salamero, O; Motlló, C; Ortín, X; Sierra, J; Solé, F
Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes
LEUKEMIA RESEARCH 101 -. .
Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A
Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.
Clinical Kidney Journal 14 543-549. .
Konturek TJ; Martinez C; Niesler B; van der Voort I; Mönnikes H; Stengel A; Goebel-Stengel M
The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome.
Frontiers in Psychiatry 11 531385-531385. .
Jatem, E; Lima, J; Montoro, B; Torres-Bondia, F; Segarra, A
Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
Kidney International Reports 6 101-109. .